PubMed:32560744 / 898-1240
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 264-274 | GO:0065007 | denotes | regulatory |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 12-13 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T12 | 247-250 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 0-342 | Sentence | denotes | Designed as a master protocol with each candidate being evaluated within its own sub-protocol (Candidate Specific Trial (CST) protocol), randomising between candidate and SoC with 2:1 allocation in favour of the candidate (N.B the first candidate has gone through regulatory approval and is expected to open to recruitment early summer 2020). |